These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2970981)

  • 1. Effect of insulin therapy on established diabetic nephropathy in rats.
    Petersen J; Ross J; Rabkin R
    Diabetes; 1988 Oct; 37(10):1346-50. PubMed ID: 2970981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W; Gao X; Zhao X; Cui D; Xia Q
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of Aesculus hippocastanum seeds on diabetic nephropathy in a streptozotocin-induced diabetic rat model.
    Elmas O; Erbas O; Yigitturk G
    Biomed Pharmacother; 2016 Oct; 83():392-396. PubMed ID: 27424320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ramipril alone compared to ramipril with eplerenone on diabetic nephropathy in streptozocin-induced diabetic rats.
    Mavrakanas TA; Cheva A; Kallaras K; Karkavelas G; Mironidou-Tzouveleki M
    Pharmacology; 2010; 86(2):85-91. PubMed ID: 20689340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerulopathy in spontaneously diabetic rat. Impact of glycemic control.
    Cohen AJ; McGill PD; Rossetti RG; Guberski DL; Like AA
    Diabetes; 1987 Aug; 36(8):944-51. PubMed ID: 3596062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxazosin prevents proteinuria and glomerular loss of heparan sulfate in diabetic rats.
    Jyothirmayi GN; Alluru I; Reddi AS
    Hypertension; 1996 May; 27(5):1108-14. PubMed ID: 8621204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose induces type 1 hexokinase gene expression in isolated glomeruli of diabetic rats and in mesangial cells.
    Henningsen C; Zahner G; Thaiss F
    Nephron Physiol; 2003; 93(3):p67-75. PubMed ID: 12660493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
    O'Brien RC; Cooper ME; Jerums G; Doyle AE
    Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated glomerulosclerosis in diabetic rats with immune complex injury.
    Abrass CK; Cohen AH
    Diabetes; 1987 Nov; 36(11):1246-53. PubMed ID: 3311853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Octreotide suppresses the kidney weight and glomerular hypertrophy in diabetic rats].
    Iwasaki S
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):247-55. PubMed ID: 8501854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Satureja khozestanica essential oil ameliorates progression of diabetic nephropathy in uninephrectomized diabetic rats.
    Tavafi M; Ahmadvand H; Tamjidipoor A; Delfan B; Khalatbari AR
    Tissue Cell; 2011 Feb; 43(1):45-51. PubMed ID: 21185580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular alterations in experimental diabetes of the rat.
    Wehner H; Petri M
    Pathol Res Pract; 1983 Mar; 176(2-4):145-57. PubMed ID: 6856514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
    Soulis-Liparota T; Cooper M; Papazoglou D; Clarke B; Jerums G
    Diabetes; 1991 Oct; 40(10):1328-34. PubMed ID: 1834497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat.
    Ellis EN; Wiegmann TB; Savin VJ
    Diabetes; 1992 Sep; 41(9):1106-12. PubMed ID: 1499863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-protein diet on experimental diabetic nephropathy in the rat.
    Wen SF; Huang TP; Moorthy AV
    J Lab Clin Med; 1985 Nov; 106(5):589-97. PubMed ID: 3903011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Prevents Hyperfiltration and Proteinuria but Not Glomerular Hypertrophy and Increases Mesangial Matrix Expansion in Diabetic Rats.
    Malatiali S; Francis I; Barac-Nieto M
    Med Princ Pract; 2017; 26(1):78-83. PubMed ID: 27643698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.